Abstract
A second case of acute myeloid leukemia (AML) with a t(2;4)(p23;q25) as the sole anomaly is reported. Our case had a de novo AML (M2); the case previously described had AML (M2) post-MDS. It is suggested that t(2;4)(p23;q25) is a new, recurrent, but rare anomaly in AML.
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Chromosome Banding
-
Chromosomes, Human, Pair 2*
-
Chromosomes, Human, Pair 4*
-
Cytarabine / administration & dosage
-
Daunorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Female
-
Humans
-
Leukemia, Myeloid, Acute / drug therapy
-
Leukemia, Myeloid, Acute / genetics*
-
Translocation, Genetic*
Substances
-
Cytarabine
-
Etoposide
-
Daunorubicin